Literature DB >> 8405856

Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach.

A M Hanby1, R Poulsom, S Singh, G Elia, R E Jeffery, N A Wright.   

Abstract

BACKGROUND: The regional differences in the distribution of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) within the stomach are not known. The aim of this study was to gain insight into these functionally obscure molecules by characterizing their distribution.
METHODS: Tissue from gastrectomy specimens removed for peptic ulceration was examined to chart the distribution of hSP and pS2, using immunohistochemistry and in situ hybridization to chart their messenger RNAs (mRNAs).
RESULTS: Colocalization of pS2 and hSP was noted in the gastric foveolar and surface epithelium throughout the stomach. In the gastric antrum and pylorus, an extremely strong hSP mRNA signal was present within pyloric-type glands; strong hSP immunostaining was also seen at this site and in mucous-neck cells. Neither pS2 mRNA nor pS2 peptide were shown within the deep portions of the pyloric glands. Within areas of intestinal metaplasia, a few goblet cells immunostained for pS2 and putative ulcer associated cell lineage was seen with a pattern of trefoil peptide localization similar to the ileum.
CONCLUSION: The detailed function of these trefoil peptides is unknown, but their distribution suggests involvement in repair-enhancing mechanisms. hSP may be an important antral peptide and both of these peptides may play a specific reparative role.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405856     DOI: 10.1016/0016-5085(93)90956-d

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  59 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 3.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

4.  Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa.

Authors:  M Pera; J Heppell; R Poulsom; F V Teixeira; J Williams
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  Further evidence to support the melanocytic origin of MDA-MB-435.

Authors:  G Ellison; T Klinowska; R F R Westwood; E Docter; T French; J C Fox
Journal:  Mol Pathol       Date:  2002-10

6.  Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing.

Authors:  Ute Schulze; Ulrike Hampel; Saadettin Sel; Tamme W Goecke; Volker Thäle; Fabian Garreis; Friedrich Paulsen
Journal:  Histochem Cell Biol       Date:  2012-04-03       Impact factor: 4.304

Review 7.  Trefoils: An unexplored natural protective shield of oral cavity.

Authors:  Akanksha Choudhary; C N Smitha; D K Suresh
Journal:  J Oral Biol Craniofac Res       Date:  2015-07-29

8.  Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans.

Authors:  Mohammed Soutto; Abbes Belkhiri; M Blanca Piazuelo; Barbara G Schneider; Dunfa Peng; Aixiang Jiang; M Kay Washington; Yasin Kokoye; Sheila E Crowe; Alexander Zaika; Pelayo Correa; Richard M Peek; Wael El-Rifai
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

9.  Altered expression of CDX-2, PDX-1 and mucin core proteins in "Ulcer-associated cell lineage (UACL)" in Crohn's disease.

Authors:  Yasunori Kaneko; Takamichi Nakamura; Masayoshi Hayama; Noriko Hosaka; Taiji Akamatsu; Hiroyoshi Ota
Journal:  J Mol Histol       Date:  2007-10-24       Impact factor: 2.611

10.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.

Authors:  James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.